The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma

Ophthalmic Surgery and Lasers

Volumn 27, Issue 9, 1996, Pages 806-809

  Mastropasqua, Leonardo ^a,b   Carpineto, Paolo ^a   Ciancaglini, Marco ^a   Gallenga, Pier Enrico ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DAPIPRAZOLE; EYE DROPS; PILOCARPINE; TIMOLOL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MUSCARINIC AGONISTS; OPHTHALMIC SOLUTIONS; PILOCARPINE; PIPERAZINES; PROSPECTIVE STUDIES; TIMOLOL; TREATMENT OUTCOME; TRIAZOLES;

EID: 0029829053     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Farrar SM, Shields MB. Current concepts in pigmentary glaucoma. Surv Ophthalmol. 1993;37:233-252.
2. Campbell OG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol. 1979;97:1667-1672.
3. Rodrigues MM, Spaeth GL, Weinreb S, Sivalingam E. Spectrum of trabecular pigmentation in open-angle glaucoma: a clinicopathologic study. Trans Am Acad Ophthalmol Otolaryngol. 1976;81:258-276.
4. Spaeth GL. Anisocoria in the pigmentary dispersion syndrome. Am J Ophthalmol. 1991;111:384.
5. Gallenga PE, Mastropasqua L. Dapiprazole in pigmentary glaucoma. New Trends Ophthalmol. 1989;3:193-196.
6. Reibaldi A. A new alpha-blocking agent. Glaucoma. 1984;6:255-257.
7. Sugar HS, Barbour FA. Pigmentary glaucoma: a rare clinical entity. Am J Ophthalmol. 1949;32:90-92.
8. Bick MW. Sex differences in pigmentary glaucoma. Am J Ophthalmol. 1962;54:831-837.
9. Scheie HG, Fleischauer HW. Idiopathic atrophy of the epithelial layers of the iris and ciliary body. Arch Ophthalmol. 1958;59:216-228.
10. Sugar HS. Pigmentary glaucoma: a 25-year review. Am J Ophthalmol. 1966;62:499-507.
11. Mapstone R. Pigment release. Br J Ophthalmol. 1981; 65:258-263.
12. Kampik A, Green WR, Quigley HA, Pierce LH. Scanning and transmission electron microscopic studies of two cases of pigment dispersion syndrome. Am J Ophthalmol. 1981;91:573-587.
13. Sugar S. Pigmentary glaucoma and die glaucoma associated with the exfoliation-pseudoexfoliation syndrome: update. Ophthalmology. 1984;4:307-310.
14. Ritch R. Pigmentary glaucoma: a self limited entity? Ann Ophthalmol. 1983;2:115-116.
15. Scheie HG, Cameron JD. Pigment dispersion syndrome: a clinical study. Br J Ophthalmol. 1981;65:264-269.
16. Weseley P, Liebmann J, Walsh JB, Ritch R. Lattice degeneration of the retina and the pigment dispersion syndrome. Am J Ophthalmol. 1992;114:539-543.
17. Richardson TM. Pigmentary glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St. Louis, MO: C. V. Mosby; 1989:981-995.
18. Lichter PR. Pigmentary glaucoma: current concepts. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:309-313.
19. Speakman JS. Pigmentary dispersion. Br J Ophthalmol. 1981;65:249-251.
20. Campbell DG. Improvement of pigmentary glaucoma and healing of transillumination defects with miotic therapy. Invest Ophthalmol Vis Sci. 1983;24:173.
21. Lichter PR, Shaffer N. Diagnostic and prognostic signs in pigmentary glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1970;74:984-998.